Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Epidermal growth factor receptor is related to poor survival in glioblastomas: single-institution experience.

Choi Y, Song YJ, Lee HS, Hur WJ, Sung KH, Kim KU, Choi SS, Kim SJ, Kim DC.

Yonsei Med J. 2013 Jan 1;54(1):101-7. doi: /10.3349/ymj.2013.54.1.101.

2.

Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.

Quan AL, Barnett GH, Lee SY, Vogelbaum MA, Toms SA, Staugaitis SM, Prayson RA, Peereboom DM, Stevens GH, Cohen BH, Suh JH.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):695-703. Epub 2005 Jun 2.

PMID:
15936158
3.

A population-based study of glioblastoma multiforme.

Paszat L, Laperriere N, Groome P, Schulze K, Mackillop W, Holowaty E.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):100-7.

PMID:
11516858
4.

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.

Azria D, Bibeau F, Barbier N, Zouhair A, Lemanski C, Rouanet P, Ychou M, Senesse P, Ozsahin M, Pèlegrin A, Dubois JB, Thèzenas S.

BMC Cancer. 2005 Jun 20;5:62.

5.

Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.

Nwokedi EC, DiBiase SJ, Jabbour S, Herman J, Amin P, Chin LS.

Neurosurgery. 2002 Jan;50(1):41-6; discussion 46-7.

PMID:
11844233
6.

12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.

Schueller P, Micke O, Palkovic S, Schroeder J, Moustakis C, Bruns F, Schuck A, Wassmann H, Willich N.

Strahlenther Onkol. 2005 Aug;181(8):500-6.

PMID:
16044217
7.

A simplified approach for the molecular classification of glioblastomas.

Le Mercier M, Hastir D, Moles Lopez X, De Nève N, Maris C, Trepant AL, Rorive S, Decaestecker C, Salmon I.

PLoS One. 2012;7(9):e45475. doi: 10.1371/journal.pone.0045475. Epub 2012 Sep 18.

8.

Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.

Odrazka K, Petera J, Kohlova T, Dolezel M, Vaculikova M, Zouhar M, Malek V, Hobza V, Latr I, Nemecek S, Sercl M, Ryska P, Blaha M, Cermakova E.

Strahlenther Onkol. 2003 Sep;179(9):615-9.

PMID:
14628127
9.

Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.

Prados MD, Scott CB, Rotman M, Rubin P, Murray K, Sause W, Asbell S, Comis R, Curran W, Nelson J, Davis RL, Levin VA, Lamborn K, Phillips TL.

Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):653-9.

PMID:
9486616
10.

Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.

Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1133-9.

PMID:
15990019
11.

Effectiveness of radiotherapy for elderly patients with glioblastoma.

Scott J, Tsai YY, Chinnaiyan P, Yu HH.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):206-10. doi: 10.1016/j.ijrobp.2010.04.033. Epub 2010 Aug 2.

PMID:
20675068
12.

Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.

Newcomb EW, Cohen H, Lee SR, Bhalla SK, Bloom J, Hayes RL, Miller DC.

Brain Pathol. 1998 Oct;8(4):655-67.

PMID:
9804374
13.

Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.

Ruano Y, Ribalta T, de Lope AR, Campos-Martín Y, Fiaño C, Pérez-Magán E, Hernández-Moneo JL, Mollejo M, Meléndez B.

Am J Clin Pathol. 2009 Feb;131(2):257-63. doi: 10.1309/AJCP64YBDVCTIRWV.

PMID:
19141386
14.

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).

Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M.

BMC Cancer. 2006 Oct 18;6:247.

15.

Primary human glioblastomas - prognostic value of clinical and histopathological parameters.

Habberstad AH, Lind-Landström T, Sundstrøm S, Torp SH.

Clin Neuropathol. 2012 Sep-Oct;31(5):361-8.

PMID:
22939176
16.

EGFR overexpression and radiation response in glioblastoma multiforme.

Barker FG 2nd, Simmons ML, Chang SM, Prados MD, Larson DA, Sneed PK, Wara WM, Berger MS, Chen P, Israel MA, Aldape KD.

Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):410-8.

PMID:
11567815
17.

[The prognostic importance of cancer-associated proteins and apoptosis in glioblastomas of the cerebral hemispheres].

Korshunov AG, Golanov AV, Sycheva RV, Pronin IN.

Zh Vopr Neirokhir Im N N Burdenko. 1999 Jan-Mar;(1):3-7. Russian.

PMID:
10335568
18.

Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas.

Saito T, Hama S, Kajiwara Y, Sugiyama K, Yamasaki F, Arifin MT, Arita K, Kurisu K.

Anticancer Res. 2006 Mar-Apr;26(2B):1351-7.

20.

Supplemental Content

Support Center